Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background Due to the heterogeneity of depressive symptoms—which can include depressed mood, anhedonia, negative cognitive biases, and altered activity levels—researchers often use a combination of depression rating scales to assess symptoms. This study sought to identify unidimensional constructs measured across rating scales for depression and to evaluate these constructs across clinical trials of a rapid-acting antidepressant (ketamine). Methods Exploratory factor analysis (EFA) was conducted on baseline ratings from the Beck Depression Inventory (BDI), the Hamilton Depression Rating Scale (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), and the Snaith-Hamilton Pleasure Rating Scale (SHAPS). Inpatients with major depressive disorder (n=76) or bipolar depression (n=43) were participating in clinical ketamine trials. The trajectories of the resulting unidimensional scores were evaluated in 41 subjects with bipolar depression who participated in clinical ketamine trials. Results The best solution, which exhibited excellent fit to the data, comprised eight factors: Depressed Mood, Tension, Negative Cognition, Impaired Sleep, Suicidal Thoughts, Reduced Appetite, Anhedonia, and Amotivation. Various response patterns were observed across the clinical trial data, both in treatment effect (ketamine versus placebo) and in degree of placebo response, suggesting that use of these unidimensional constructs may reveal patterns not observed with traditional scoring of individual instruments. Limitations Limitations include: 1) small sample (and related inability to confirm measurement invariance); 2) absence of an independent sample for confirmation of factor structure; and 3) the treatment-resistant nature of the population, which may limit generalizability. Conclusions The empirical identification of unidimensional constructs creates more refined scores that may elucidate the connection between specific symptoms and underlying pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hu, L., & Bentler, P. M. (1999) · Structural Equation Modeling A Multidisciplinary Journal · doi:10.1080/10705519909540118 · Cited by 108,788
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Self-citationResting-state connectivity biomarkers define neurophysiological subtypes of depression
Drysdale, A. T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., Fetcho, R. N., Zebley, B., Oathes, D. J., Etkin, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4246 · Cited by 2,170 · cited 1×
“The literature on depressive biotypes is growing rapidly—in part related to imaging connectivity analyses (Drysdale et al., 2017; Williams, 2017) and the ongoing search for central or peripheral biomarkers (Lamers et al., 2013)—and we believe that careful parcellation of depressive symptoms and…”
BackgroundA scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale
Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., & Trigwell, P. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.1.99 · Cited by 1,778
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579 · cited 1×
“…(e.g, anhedonia or approach motivation) into specific neural circuits in patient samples, followed by an experimental paradigm to induce anhedonic symptoms in non-depressed healthy control participants, and finally into preclinical models of anhedonia in animal studies (Treadway and Zald, 2011).”
BackgroundCuthbert, B. N. (2014) · World Psychiatry · doi:10.1002/wps.20087 · Cited by 1,377
Anticipatory and consummatory components of the experience of pleasure: A scale development study
Gard, D. E., Gard, M. G., Kring, A. M., & John, O. P. (2006) · Journal of Research in Personality · doi:10.1016/j.jrp.2005.11.001 · Cited by 1,015
Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963 · cited 3×
“Details regarding study designs can be found elsewhere (Diazgranados et al., 2010b; Ibrahim et al., 2012; Zarate et al., 2012, 2006).”
BackgroundSelf-citationZarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811 · cited 3×
“Details regarding study designs can be found elsewhere (Diazgranados et al., 2010b; Ibrahim et al., 2012; Zarate et al., 2012, 2006).”
BackgroundSelf-citationLamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.144 · Cited by 691
Cited by
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Self-citationCBT at the crossroads: the rise of transdiagnostic treatments.
Schaeuffele, C., Schulz, A., Knaevelsrud, C., Renneberg, B., & Boettcher, J. (2021) · International Journal of Cognitive Therapy · doi:10.1007/s41811-020-00095-2 · Cited by 150
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Henter, I. D., Park, L. T., & Zarate, C. A. (2021) · CNS Drugs · doi:10.1007/s40263-021-00816-x · Cited by 142
“It is possible that identifying unidimensional constructs that can help parse the heterogeneity of depressive symptoms will ultimately create more refined rating scale scores to more successfully illuminate connections between specific symptoms and underlying pathophysiology [131].”
BackgroundSelf-citationKetamine modulates fronto-striatal circuitry in depressed and healthy individuals
Mkrtchian, A., Evans, J. W., Kraus, C., Yuan, P., Kadriu, B., Nugent, A. C., Roiser, J. P., & Zarate, C. A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00878-1 · Cited by 110
Self-citationCognitive dysfunction in major depression: From assessment to novel therapies
Atique-Ur-Rehman, H., & Neill, J. C. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.013 · Cited by 72
Thomas, R. K., Baker, G., Lind, J., & Dursun, S. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118793104 · Cited by 69
Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
Jollant, F., Colle, R., Nguyen, T. M. L., Corruble, E., Gardier, A. M., Walter, M., Abbar, M., & Wagner, G. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231151327 · Cited by 56
Nugent, A. C., Ballard, E. D., Gilbert, J. R., Tewarie, P. K., Brookes, M. J., & Zarate, C. A. (2020) · NeuroImage: Clinical · doi:10.1016/j.nicl.2020.102378 · Cited by 34
“Finally, because our sample size was relatively small, any attempt to cluster participants into biotypes would be statistically untenable; therefore, we relied on a previously reported exploratory factor analysis (Ballard et al., 2018) that examined symptom clustering in a larger group of MDD participants.”
InfluentialSelf-citationPsychological pain and suicidal behavior: A review
Baryshnikov, I., & Isometsä, E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.981353 · Cited by 33
The conundrum of depression clinical trials: one size does not fit all
Khan, A., Mar, K. F., & Brown, W. A. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000229 · Cited by 30
“The way that these symptoms can interact with one another in a system (Fried, 2015; Ballard et al., 2018) has not been duly considered.”
BackgroundMagnetoencephalographic correlates of suicidal ideation in major depression
Gilbert, J. R., Ballard, E. D., Galiano, C. S., Nugent, A. C., & Zarate, C. A. (2020) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.11.011 · Cited by 28
“Due to concerns of the overlap between SI and other symptoms of depression, SI was assessed using the results of an exploratory factor analysis (EFA) across multiple assessments of depression and anhedonia, specifically the MADRS, HAMD, SHAPS and BDI (43).”
MethodInfluentialSelf-citationGilbert, J. R., Gerner, J. L., Burton, C. R., Nugent, A. C., Zarate, C. A., & Ballard, E. D. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.025 · Cited by 18
Self-citationProspective association of psychological pain and hopelessness with suicidal thoughts
Ballard, E. D., Farmer, C. A., Gerner, J., Bloomfield-Clagett, B., Park, L. T., & Zarate, C. A. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.033 · Cited by 16
Self-citationGrützmann (2022) · doi:10.1016/j.bpsgos.2021.07.003 · Cited by 3
Metadata
- Authors
- Ballard, E. D., Yarrington, J. S., Farmer, C. A., Lener, M. S., Kadriu, B., Lally, N., Williams, D., Machado-Vieira, R., Niciu, M. J., Park, L., & Zarate, C. A.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 231
- Pages
- 51-57
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2789400649
- Cited by
- 74
- References
- 19
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.